These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 21930917)

  • 1. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
    Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
    Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.
    Marchiq I; Albrengues J; Granja S; Gaggioli C; Pouysségur J; Simon MP
    Oncotarget; 2015 Sep; 6(28):24636-48. PubMed ID: 26284589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.
    Benton CR; Yoshida Y; Lally J; Han XX; Hatta H; Bonen A
    Physiol Genomics; 2008 Sep; 35(1):45-54. PubMed ID: 18523157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
    Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
    Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
    Nancolas B; Sessions RB; Halestrap AP
    Biochem J; 2015 Feb; 466(1):177-88. PubMed ID: 25437897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
    Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
    J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
    Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
    J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.
    Ovens MJ; Manoharan C; Wilson MC; Murray CM; Halestrap AP
    Biochem J; 2010 Oct; 431(2):217-25. PubMed ID: 20695846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
    Guan X; Bryniarski MA; Morris ME
    AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart.
    Zhu Y; Wu J; Yuan SY
    Cell Physiol Biochem; 2013; 32(3):663-74. PubMed ID: 24030048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
    Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
    Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
    Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
    Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.